| Literature DB >> 28040456 |
A S Kononikhin1, N L Starodubtseva2, V V Chagovets3, A Y Ryndin3, A A Burov3, I A Popov4, A E Bugrova5, R A Dautov6, A O Tokareva7, Y L Podurovskaya3, O V Ionov3, V E Frankevich3, E N Nikolaev8, G T Sukhikh3.
Abstract
Invasiveness of examination and therapy methods is a serious problem for intensive care and nursing of premature infants. Exhaled breath condensate (EBC) is the most attractive biofluid for non-invasive methods development in neonatology for monitoring the status of intubated infants. The aim of the study was to propose an approach for EBC sampling and analysis from mechanically ventilated neonates. EBC collection system with good reproducibility of sampling was demonstrated. Discovery-based proteomic and metabolomic studies were performed using nano-HPLC coupled to high resolution MS. Label-free semi-quantitative data were compared for intubated neonates with congenital pneumonia (12 infants) and left-sided congenital diaphragmatic hernia (12 infants) in order to define disease-specific features. Totally 119 proteins and 164 metabolites were found. A number of proteins and metabolites that can act as potential biomarkers of respiratory diseases were proposed and require further validation.Entities:
Keywords: Exhaled breath condensate (EBC); HPLC; Mass spectrometry; Metabolomics; Newborns; Pneumonia; Proteomic; Respiratory diseases
Mesh：
Substances：
Year: 2016 PMID： 28040456 DOI： 10.1016/j.jchromb.2016.12.036
Source DB: PubMed Journal: J Chromatogr B Analyt Technol Biomed Life Sci ISSN： 1570-0232 Impact factor: 3.205